Roderick V Jensen

Title: Roderick V Jensen: Innovator in Diagnostic and Prognostic Testing

Introduction

Roderick V Jensen is a notable inventor based in Pelham, MA (US). He has made significant contributions to the field of diagnostic and prognostic testing, particularly in relation to cancer research. With a total of 3 patents, his work has the potential to impact the way biological states and conditions are diagnosed.

Latest Patents

Jensen's latest patents focus on methods for diagnosing biological states or conditions based on ratios of gene expression data from tissue samples, especially cancer tissue samples. His inventions provide sets of genes that are expressed differentially in malignant pleural mesothelioma. These sets can be utilized to distinguish between normal and malignant tissues, as well as between different classes of malignant tissues. Consequently, his diagnostic assays are designed for tumor classification, predicting tumor outcomes, selecting and monitoring treatment regimens, and tracking tumor progression or regression.

Career Highlights

Throughout his career, Roderick V Jensen has worked with prestigious institutions such as Brigham and Women's Hospital, Inc. and Wesleyan University. His experience in these organizations has allowed him to collaborate with leading experts in the field, further enhancing his contributions to medical science.

Collaborations

Some of Jensen's notable coworkers include Steven R Gullans and Gavin J Gordon. Their collaborative efforts have likely played a role in advancing the research and development of diagnostic methods in cancer treatment.

Conclusion

Roderick V Jensen's innovative work in diagnostic and prognostic testing showcases his commitment to improving cancer diagnosis and treatment. His contributions are invaluable to the medical community and have the potential to save lives through early detection and effective treatment strategies.